TABLE 3

Comparison of Tumor Parameters at Baseline and at 8 Weeks in Individual PD and non-PD Patients

Baseline8 wk% change
Patient typePatient no.KiSUVmaxSUVmeanKiSUVmaxSUVmeanKiSUVmaxSUVmean
PD10.03325.712.00.07537.116.9145.058.851.8
20.07132.620.20.09132.619.638.62.13.3
30.04749.621.90.12185.946.8140.263.298.4
40.08330.719.40.11044.023.134.943.020.4
Non-PD10.06725.811.70.06325.7412.72−4.7−4.19.4
20.14560.934.40.12146.9626.64−14.5−20.0−20.7
30.07837.621.70.07626.7016.72−1.3−28.0−23.1
40.04538.819.80.03630.3815.47−19.8−21.7−21.8
50.05126.114.40.05127.3515.405.412.311.4
60.04012.425.30.07937.5918.7797.548.250.8
70.05525.014.80.06334.7318.3115.632.523.0
80.05927.613.40.05123.6814.0210.130.130.5
P*P = <0.01P = 0.067P = 0.153
  • * PD vs. non-PD.

  • PD data are for 20 tumors; non-PD data are for 32 tumors. Units are mL min−1 mL−1 for Ki and g/mL for SUV.